|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
US4863940A
(en)
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
WO1990007330A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for specific useful pharmaceutical compounds
|
|
WO1991013889A1
(en)
|
1990-03-13 |
1991-09-19 |
Fisons Plc |
Immunosuppressive macrocyclic compounds
|
|
AU668347B2
(en)
|
1990-11-21 |
1996-05-02 |
Torrey Pines Institute For Molecular Studies |
Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
EP0541946B1
(de)
|
1991-10-07 |
1996-07-17 |
Hoechst Aktiengesellschaft |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
AU4544993A
(en)
|
1992-06-24 |
1994-01-24 |
Cortex Pharmaceuticals, Inc. |
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
CA2174311A1
(en)
|
1993-10-07 |
1995-04-13 |
Gregory James Pacofsky |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
EP0910564B1
(en)
|
1995-11-28 |
2007-10-31 |
Cephalon, Inc. |
D-amino acid derived inhibitors of cysteine and serine proteases
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
AU7179598A
(en)
|
1996-11-13 |
1998-06-03 |
Cephalon, Inc. |
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
EP0944582B1
(de)
|
1996-12-11 |
2003-07-02 |
Abbott GmbH & Co. KG |
Ketobenzamide als calpain-inhibitoren
|
|
CA2284041C
(en)
|
1997-03-14 |
2010-05-18 |
Smithkline Beecham Corporation |
Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
|
|
US6100267A
(en)
|
1997-03-14 |
2000-08-08 |
Smithkline Beecham Corporation |
Quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
WO1999050264A1
(en)
|
1998-03-30 |
1999-10-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Quinazoline derivatives
|
|
HRP20000787A2
(en)
|
1998-04-20 |
2001-08-31 |
Basf Ag |
New substituted amides, their production and their use
|
|
ES2325140T3
(es)
|
1998-04-20 |
2009-08-26 |
ABBOTT GMBH & CO. KG |
Amidas sustituidas con heterociclos como inhibidores de la calpaina.
|
|
DE19817459A1
(de)
*
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
HRP20000788A2
(en)
|
1998-04-20 |
2001-06-30 |
Basf Ag |
Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
|
|
ATE524440T1
(de)
|
1998-05-25 |
2011-09-15 |
Abbott Gmbh & Co Kg |
Heterocyclische substituierte amide, deren herstellung und anwendung
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
CA2355215A1
(en)
|
1998-12-28 |
2000-07-06 |
Jim Wells |
Identifying small organic molecule ligands for binding
|
|
EA200100972A1
(ru)
*
|
1999-03-15 |
2002-02-28 |
Аксис Фармасьютикалз, Инк. |
Новые соединения и композиции как ингибиторы протеаз
|
|
HK1039110A1
(zh)
|
1999-03-15 |
2002-04-12 |
Axys Pharmaceuticals, Inc. |
以新颖的合成物及组分作为蛋白酶抑制剂
|
|
EP1165490B1
(en)
|
1999-03-16 |
2006-08-16 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
HK1047582B
(zh)
|
1999-06-23 |
2005-03-04 |
萨诺费－阿文蒂斯德国有限公司 |
取代的苯並咪唑
|
|
EP1254901A4
(en)
|
2000-01-26 |
2003-03-05 |
Ono Pharmaceutical Co |
5-CHAIN CYCLIC COMPOUNDS, CONTAINING NITROGEN, AND MEDICINAL PRODUCTS CONTAINING THE SAME AS ACTIVE INGREDIENTS
|
|
WO2001089584A2
(en)
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
WO2003010180A1
(en)
|
2001-07-23 |
2003-02-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for rnai mediated inhibition of gene expression in mammals
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
BR0307266A
(pt)
|
2002-01-31 |
2004-12-07 |
Morphochem Ag Komb Chemie |
Compostos que inibem a atividade do fator xa
|
|
RU2368600C2
(ru)
|
2002-04-25 |
2009-09-27 |
Оно Фармасьютикл Ко., Лтд. |
Производные дикетогидразина, фармацевтическая композиция, содержащая такие производные в качестве активного ингредиента, и их применение
|
|
US7122580B2
(en)
|
2002-08-09 |
2006-10-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
ES2387803T3
(es)
|
2003-01-08 |
2012-10-02 |
Novartis Vaccines And Diagnostics, Inc. |
Agentes antibacterianos
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
US20060281714A1
(en)
|
2003-07-21 |
2006-12-14 |
Johann Zimmermann |
Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
|
|
WO2005014532A1
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
JP2007502278A
(ja)
|
2003-08-14 |
2007-02-08 |
メルク エンド カムパニー インコーポレーテッド |
アルツハイマー病の治療のための大員環β−セクレターゼ阻害剤
|
|
JPWO2005102381A1
(ja)
|
2004-04-26 |
2008-03-06 |
小野薬品工業株式会社 |
カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤
|
|
WO2006052722A1
(en)
|
2004-11-09 |
2006-05-18 |
Smithkline Beecham Corporation |
Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
|
|
EP1868604B1
(en)
|
2005-01-21 |
2014-08-13 |
President and Fellows of Harvard College |
Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
|
|
WO2006122237A2
(en)
*
|
2005-05-11 |
2006-11-16 |
University Of Florida Research Foundation, Inc. |
Imaging of neural and organ injury or damage
|
|
WO2007016476A2
(en)
|
2005-08-01 |
2007-02-08 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
WO2007089618A2
(en)
|
2006-01-27 |
2007-08-09 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US20070207144A1
(en)
|
2006-02-16 |
2007-09-06 |
Lee Rubin |
Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
|
|
JP2009531315A
(ja)
|
2006-03-16 |
2009-09-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
重水素化ｃ型肝炎プロテアーゼインヒビター
|
|
JP2009539815A
(ja)
|
2006-06-09 |
2009-11-19 |
アストラゼネカ アクチボラグ |
固形腫瘍の治療用のａ５ｂ１アンタゴニストとしてのＮ−（ベンゾイル）−Ｏ−［２−（ピリジン−２−イルアミノ）エチル］−Ｌ−チロシン誘導体と関連化合物
|
|
WO2008048121A2
(en)
|
2006-10-18 |
2008-04-24 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
CL2007003879A1
(es)
*
|
2006-12-29 |
2008-07-04 |
Basf Ag |
Compuestos derivados de aril-carboxamida; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alzheimer, epilepsia y parkinson.
|
|
US8575208B2
(en)
|
2007-02-27 |
2013-11-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
CA2691987C
(en)
|
2007-06-12 |
2016-08-16 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
TW201010700A
(en)
|
2008-08-25 |
2010-03-16 |
Piramal Lifesciences Ltd |
Diacylglycerol acyltransferase inhibitors
|
|
US8629157B2
(en)
|
2009-01-05 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidine compounds which modulate the CB2 receptor
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
WO2011082285A1
(en)
|
2009-12-30 |
2011-07-07 |
Avila Therapeutics, Inc. |
Ligand-directed covalent modification of protein
|
|
WO2011133346A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc. |
Peripheral opioid agonists and peripheral opioid antagonists
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
EP2606031B1
(en)
|
2010-08-20 |
2017-09-27 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
US20120095211A1
(en)
|
2010-09-22 |
2012-04-19 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
MX2013006419A
(es)
|
2010-12-09 |
2013-12-16 |
Abbvie Inc |
Compuestos carboxamida y su uso como inhibidores de calpaina v.
|
|
EP2683394B1
(en)
|
2011-03-09 |
2021-01-06 |
Signature Therapeutics, Inc. |
Active agent prodrugs with heterocyclic linkers
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
DK2697246T3
(en)
|
2011-04-15 |
2018-05-28 |
Genesis Tech Limited |
SELECTIVE CYSTEIN PROTEASE INHIBITORS AND USES THEREOF
|
|
EP4706663A3
(en)
|
2011-08-30 |
2026-05-20 |
Trustees Of Tufts College |
FAP-ACTIVATED PROTEASOME INHIBITORS USED TO TREAT SOLID TUMORS
|
|
MX2014006211A
(es)
|
2011-11-25 |
2014-08-08 |
Hoffmann La Roche |
Nuevos derivados de pirrolidina como inhibidores de catepsina.
|
|
RU2625796C2
(ru)
|
2012-01-11 |
2017-07-19 |
Ф. Хоффманн-Ля Рош Аг |
Макроциклические амиды в качестве ингибиторов протеазы
|
|
US9150545B2
(en)
|
2012-04-03 |
2015-10-06 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
CA2872147A1
(en)
|
2012-05-02 |
2013-11-07 |
Kansas State University Research Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
US20150299250A1
(en)
|
2012-11-16 |
2015-10-22 |
Adelaide Research & Innovation Pty Ltd |
Macrocyclic compounds and uses thereof
|
|
JP6434968B2
(ja)
|
2013-07-02 |
2018-12-05 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｒｏｃｋ阻害剤としての三環式ピリド−カルボキサミド誘導体
|
|
UY35834A
(es)
|
2013-11-14 |
2015-05-29 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
|
|
EP3107952B1
(en)
|
2014-02-19 |
2018-09-26 |
ETH Zurich |
Method for the generation of chemical libraries
|
|
WO2015140199A1
(de)
*
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
KR20170027721A
(ko)
|
2014-05-20 |
2017-03-10 |
알큐엑스 파마슈티컬스, 인크. |
마크로시클릭 광범위 항생제
|
|
US20150368213A1
(en)
*
|
2014-06-20 |
2015-12-24 |
The University of Montana, Missoula, MT |
Novel Inhibitors of System Xc-
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
JP6526796B2
(ja)
|
2014-09-04 |
2019-06-05 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｆｘｉａ阻害剤であるジアミドマクロ環
|
|
US11219670B2
(en)
|
2014-09-05 |
2022-01-11 |
The Johns Hopkins University |
Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
RU2732405C2
(ru)
|
2015-07-02 |
2020-09-16 |
Тёрнинг Поинт Терапьютикс, Инк. |
Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ
|
|
US9938273B2
(en)
|
2015-12-07 |
2018-04-10 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
WO2017156074A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Calpain modulators and methods of production and use thereof
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
AU2017290705B2
(en)
|
2016-06-29 |
2021-08-26 |
Rascal Therapeutics, Inc. |
Compounds and compositions for the treatment of cancer
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US10934261B2
(en)
|
2016-09-28 |
2021-03-02 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US20210347727A1
(en)
|
2017-06-23 |
2021-11-11 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
CN112166111A
(zh)
|
2018-03-28 |
2021-01-01 |
布莱德治疗公司 |
治疗纤维化疾病的方法
|
|
CA3095164A1
(en)
|
2018-03-28 |
2019-10-03 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US20210253642A1
(en)
|
2018-05-09 |
2021-08-19 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
EP3820864A4
(en)
|
2018-06-28 |
2022-03-30 |
Blade Therapeutics, Inc. |
METHOD OF TREATMENT OF HEPATIC FIBROSIS USING CALPAIN INHIBITORS
|
|
US20210238192A1
(en)
|
2018-06-29 |
2021-08-05 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|